Drug application
METHYLDOPA AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE, METHYLDOPA)
Drugs@FDA ANDA 072507 · DAVA PHARMS INC
Key facts
| Drug name | METHYLDOPA AND HYDROCHLOROTHIAZIDE |
|---|---|
| Active ingredients | HYDROCHLOROTHIAZIDE, METHYLDOPA |
| Application type | ANDA |
| Application number | 072507 |
| Company | DAVA PHARMS INC |
| Dosage forms | TABLET, ORAL |
| Strength | 15MG;250MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Jun 2, 1989 |
At a glance
- 1–9 Submissions
- 1–9 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.